“This will be a significant cost saving for many of our urological patients with erectile dysfunction, including those experiencing side effects from diabetes or prostate cancer treatment,” Dr Katz said in a statement on Thursday. Selpercatinib is the first drug from Loxo’s pipeline that Lilly has brought to market. Prior to the acquisition, Loxo won […]